Surgical and Medical Management of Pancreatic Tumors: Indication, Techniques, and Prognostic Factors
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Surgical Oncology".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 340
Special Issue Editors
2. Unit of Hepato-Biliary and Pancreatic Surgery, “F. Miulli” General Hospital, Acquaviva delle Fonti, 70021 Bari, Italy
Interests: HPB surgery; minimally invasive and robotic surgery
Interests: HPB surgery; minimally invasive and robotic surgery
2. Unit of Hepato-Biliary and Pancreatic Surgery, “F. Miulli” General Hospital, Acquaviva delle Fonti, 70021 Bari, Italy
Interests: gastroiontestinal cancers; robotic surgery; surgical oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pancreatic masses represent a clinically significant concern due to their rising global incidence, with pancreatic cancer now ranking among the top causes of cancer-related deaths worldwide.
Pancreatic masses represent a heterogeneous spectrum of neoplasms, with the most common being pancreatic ductal adenocarcinoma, neuroendocrine tumors, and IPMNs. Timely and accurate differentiation among these entities is essential in devising effective therapeutic strategies. Recent advancements in diagnostic modalities, surgical techniques, and perioperative care have significantly influenced the management of pancreatic tumors.
Pancreatic neoplasms can significantly impact patient outcomes based on their nature, origin, and behavior. Some of these tumors may benefit from upfront surgery, while others may need medical therapy alone or prior to surgery.
Pancreatic surgery can be performed using open techniques or minimally invasive approaches, such as laparoscopic or robotic-assisted surgery, depending on the specific case and the surgeon’s experience.
This Special Issue will focus on the surgical and medical management of patients with pancreatic tumors, addressing critical aspects such as neoadjuvant therapy, adjuvant therapy, surgical techniques, short- and long-term outcomes, survival rates, and prognostic factors in recurrence.
Additionally, this Special Issue will explore the factors influencing outcomes, short- and long-term survival, and recurrence rates.
By addressing these multifaceted topics, this Special Issue will provide a comprehensive overview of the current state of the management of pancreatic tumors, offering insights into improving patient outcomes.
This Special Issue will showcase original research, reviews, and case reports that highlight innovative treatment approaches or novel therapies in the field of pancreatic tumors.
We look forward to receiving your contributions.
Dr. Michele Tedeschi
Dr. Antonella Delvecchio
Dr. Riccardo Memeo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic tumors
- pancreatic surgery
- neoadjuvant therapy
- adjuvant therapy
- short- and long-term outcomes
- pancreatic diseases
- surgical complication
- recurrence rate
- medical management
- prognostic factors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
